JP2021517895A5 - - Google Patents
Info
- Publication number
- JP2021517895A5 JP2021517895A5 JP2020548799A JP2020548799A JP2021517895A5 JP 2021517895 A5 JP2021517895 A5 JP 2021517895A5 JP 2020548799 A JP2020548799 A JP 2020548799A JP 2020548799 A JP2020548799 A JP 2020548799A JP 2021517895 A5 JP2021517895 A5 JP 2021517895A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- hpv
- modified immune
- immune cells
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862641988P | 2018-03-12 | 2018-03-12 | |
| US62/641,988 | 2018-03-12 | ||
| US201962794517P | 2019-01-18 | 2019-01-18 | |
| US62/794,517 | 2019-01-18 | ||
| US201962812225P | 2019-02-28 | 2019-02-28 | |
| US62/812,225 | 2019-02-28 | ||
| PCT/US2019/021703 WO2019178005A2 (en) | 2018-03-12 | 2019-03-11 | Methods for treating hpv-associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517895A JP2021517895A (ja) | 2021-07-29 |
| JP2021517895A5 true JP2021517895A5 (enExample) | 2022-03-22 |
Family
ID=65904594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020548799A Pending JP2021517895A (ja) | 2018-03-12 | 2019-03-11 | Ｈｐｖ関連疾患を処置するための方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12599656B2 (enExample) |
| EP (1) | EP3765073A2 (enExample) |
| JP (1) | JP2021517895A (enExample) |
| KR (1) | KR20200130371A (enExample) |
| CN (1) | CN112105383A (enExample) |
| AU (1) | AU2019234549B2 (enExample) |
| BR (1) | BR112020018609A2 (enExample) |
| CA (1) | CA3093826A1 (enExample) |
| CO (1) | CO2020012583A2 (enExample) |
| CR (1) | CR20200461A (enExample) |
| IL (1) | IL277190B2 (enExample) |
| MA (1) | MA52003A (enExample) |
| MX (1) | MX2020009441A (enExample) |
| PE (1) | PE20201201A1 (enExample) |
| PH (1) | PH12020551437A1 (enExample) |
| SG (1) | SG11202008863XA (enExample) |
| TW (1) | TW202003025A (enExample) |
| WO (1) | WO2019178005A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3344575B1 (en) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| CA3023092A1 (en) | 2016-05-03 | 2017-11-09 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to induce tolerance |
| AU2019234549B2 (en) | 2018-03-12 | 2026-02-12 | Sqz Biotechnologies Company | Methods for treating HPV-associated diseases |
| US20240374654A2 (en) * | 2018-03-12 | 2024-11-14 | Stemcell Technologies Canada Inc. | Intracellular delivery of biomolecules to modify immune response |
| CA3131701A1 (en) * | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
| KR20210149791A (ko) | 2019-04-08 | 2021-12-09 | 에스큐지 바이오테크놀로지스 컴퍼니 | 페이로드를 세포 내로 전달하기 위한 시스템에서 이용하기 위한 카트리지 |
| AU2020275413A1 (en) | 2019-05-14 | 2021-12-23 | Cedars-Sinai Medical Center | TL1A patient selection methods, systems, and devices |
| CN112007149A (zh) * | 2019-05-29 | 2020-12-01 | 思格(苏州)生物科技有限公司 | 一种新型复合免疫佐剂及其应用 |
| CN110846318A (zh) * | 2019-11-29 | 2020-02-28 | 华中科技大学同济医学院附属同济医院 | 治疗hpv感染的纳米粒制剂中新的靶向序列以及新pbae的制备方法 |
| JP2023527690A (ja) | 2020-05-11 | 2023-06-30 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 改変ｐｂｍｃと免疫抱合体との併用療法 |
| JP2023534740A (ja) * | 2020-07-24 | 2023-08-10 | 四川大学華西医院 | Ｅｂｖを標的とした同種異系ｂ細胞ワクチン及びその調製方法 |
| KR20230058388A (ko) | 2020-07-29 | 2023-05-03 | 에스큐지 바이오테크놀로지스 컴퍼니 | 무핵 세포를 사용해 돌연변이체 ras에 대한 면역 반응을 자극하는 방법 |
| US20250255961A1 (en) | 2020-07-29 | 2025-08-14 | Stemcell Technologies Canada Inc. | Methods to stimulate immune responses to mutant ras using nucleated cells |
| CN116406283A (zh) * | 2020-09-02 | 2023-07-07 | Sqz生物技术公司 | 用于使用有核细胞刺激对蛋白质的hla未知免疫应答的方法 |
| US20220296691A1 (en) * | 2020-12-29 | 2022-09-22 | Sqz Biotechnologies Company | Methods for treating cancer with activating antigen carriers |
| EP4271407A1 (en) | 2020-12-29 | 2023-11-08 | SQZ Biotechnologies Company | Formulations of activating antigen carriers |
| US12150982B2 (en) * | 2020-12-29 | 2024-11-26 | Stemcell Technologies Canada Inc. | Formulations of PBMCs |
| EP4271711A1 (en) * | 2020-12-29 | 2023-11-08 | SQZ Biotechnologies Company | Methods for treating cancers with modified pbmcs |
| US20250327027A1 (en) | 2021-07-29 | 2025-10-23 | Stemcell Technologies Canada Inc. | Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery |
| JP2024545582A (ja) | 2021-11-11 | 2024-12-10 | ステムセル テクノロジーズ カナダ インコーポレイテッド | マイクロ流体送達による増強された腫瘍浸潤リンパ球を作製する方法 |
| WO2023196884A1 (en) | 2022-04-06 | 2023-10-12 | Juno Therapeutics, Inc. | Detection assay for human papillomavirus (hpv) type 16 (hpv-16) |
| WO2024026491A2 (en) | 2022-07-28 | 2024-02-01 | Sqz Biotechnologies Company | Enhanced antigen presenting cell formulations |
| EP4561620A1 (en) | 2022-07-28 | 2025-06-04 | Stemcell Technologies Canada Inc. | Methods for treating cancer with enhanced antigen presenting cells |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2502621C3 (de) | 1975-01-23 | 1978-09-14 | Kernforschungsanlage Juelich Gmbh, 5170 Juelich | Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen |
| US4376634A (en) | 1980-05-30 | 1983-03-15 | Mallinckrodt, Inc. | Assay kit having syringe, dilution device and reagents within sealed container |
| FR2569477B1 (fr) | 1984-08-24 | 1987-01-02 | Descartes Universite Rene | Appareil et procede pour la determination de la deformabilite des globules rouges du sang |
| JP2720161B2 (ja) | 1988-02-01 | 1998-02-25 | 株式会社アドバンス | 細胞変形能測定装置 |
| JP2685544B2 (ja) | 1988-11-11 | 1997-12-03 | 株式会社日立製作所 | 血液フィルタおよび血液検査方法並びに血液検査装置 |
| JP2532707B2 (ja) | 1990-03-08 | 1996-09-11 | 佑二 菊池 | 血液回路及びこれを用いた血液測定装置及び血液測定方法 |
| AU2002252073A1 (en) | 2001-02-22 | 2002-09-12 | The Scepens Eye Research Institute, Inc. | Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| WO2003020039A1 (en) | 2001-08-28 | 2003-03-13 | Rush-Presbyterian-St. Luke's Medical Center | Immune tolerance to predetermined antigens |
| US7501278B2 (en) | 2002-06-05 | 2009-03-10 | Panasonic Corporation | Extracellular potential measuring device and method for fabricating the same |
| US20060134067A1 (en) | 2003-02-18 | 2006-06-22 | Maxcyte, Inc. | Loading of cells with antigens by electroporation |
| AU2003290460A1 (en) | 2003-12-24 | 2005-07-14 | Leiden University Medical Center | Synthetic protein as tumor-specific vaccine |
| LT3173073T (lt) | 2004-05-03 | 2025-01-10 | Ipsen Biopharm Ltd. | Liposomos, skirtos vaistų pristatymui |
| WO2005123905A1 (ja) | 2004-06-17 | 2005-12-29 | Ken Nakata | 生体力学的刺激負荷による細胞培養方法及びその装置 |
| CN100591761C (zh) | 2004-08-19 | 2010-02-24 | 加的夫大学学院咨询有限公司 | 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途 |
| US20060134772A1 (en) | 2004-11-18 | 2006-06-22 | The Regents Of The University Of California | System for locating cells and for cellular analysis |
| US7704743B2 (en) | 2005-03-30 | 2010-04-27 | Georgia Tech Research Corporation | Electrosonic cell manipulation device and method of use thereof |
| EP3263581B2 (en) | 2005-05-17 | 2025-07-09 | University of Connecticut | Compositions and methods for immunomodulation in an organism |
| US9005974B2 (en) | 2005-12-09 | 2015-04-14 | Academish Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of cells |
| US8293524B2 (en) | 2006-03-31 | 2012-10-23 | Fluxion Biosciences Inc. | Methods and apparatus for the manipulation of particle suspensions and testing thereof |
| US20070249038A1 (en) | 2006-04-21 | 2007-10-25 | Andrea Adamo | Microfluidic device for single cell targeted operations |
| CA2662826A1 (en) | 2006-08-17 | 2008-02-21 | Massachusetts Institute Of Technology | Method and apparatus for microfluidic injection |
| WO2008046251A1 (fr) * | 2006-10-19 | 2008-04-24 | Sunbio Biotech Pharmaceuticals(Tianjin) Co., Ltd. | Protéines hybrides contenant un domaine n de la calréticuline humaine et des protéines e6 ou e7 du papillomavirus humain de type 16, et utilisations associées |
| WO2008098094A1 (en) | 2007-02-06 | 2008-08-14 | Network Biosystems, Inc. | Devices and methods for the performance of miniaturized in vitro assays |
| US20080311140A1 (en) | 2007-05-29 | 2008-12-18 | Baylor College Of Medicine | Antigen specific immunosuppression by dendritic cell therapy |
| MX2009012922A (es) | 2007-05-31 | 2010-07-05 | Academisch Ziekenhuis Leiden H | Vacunacion intradermica de un peptido del virus del papiloma humano. |
| FR2919804B1 (fr) | 2007-08-08 | 2010-08-27 | Erytech Pharma | Composition et vaccin therapeutique anti-tumoral |
| GB0718160D0 (en) | 2007-09-18 | 2007-10-24 | Medical Res Council | Methods |
| CN101874201B (zh) | 2007-11-28 | 2012-08-15 | 柯尼卡美能达精密光学株式会社 | 血液流动性测量装置及血液流动性测量方法 |
| US20090280518A1 (en) | 2008-05-12 | 2009-11-12 | Massachusetts Institute Of Technology | System for high throughput measurement of mechanical properties of cells |
| JP5137129B2 (ja) | 2008-07-23 | 2013-02-06 | 国立大学法人山口大学 | 血液細胞の力学的特性測定装置 |
| US9115340B2 (en) | 2008-08-08 | 2015-08-25 | Agency For Science Technology & Research | Microfluidic continuous flow device |
| CA3017298C (en) | 2009-05-15 | 2021-09-28 | Irx Therapeutics, Inc. | Compositions comprising primary cell-derived biologics for enhancing immune responses in patients |
| CA2766907A1 (en) | 2009-07-06 | 2011-01-13 | Novartis Ag | Self replicating rna molecules and uses thereof |
| US9364831B2 (en) | 2009-08-08 | 2016-06-14 | The Regents Of The University Of California | Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting |
| AU2010311515B2 (en) | 2009-10-27 | 2014-02-20 | Erytech Pharma | Composition to induce specific immune tolerance |
| MX344460B (es) | 2009-12-23 | 2016-12-14 | Cytovera Inc * | Sistema y método para la filtración de partículas. |
| US20110293558A1 (en) | 2010-03-22 | 2011-12-01 | Massachusetts Institute Of Technology | Material properties of t cells and related methods and compositions |
| DE11787873T1 (de) | 2010-11-25 | 2013-12-12 | Imnate Sarl | Immugene Peptide zur Verwendung bei der Vorbeugung und/oder Behandlung von Infektionskrankheiten, Autoimmunerkrankungen, Immunreaktionen auf Allofaktoren, allergischen Erkrankungen, Tumoren, Transplantatabstossungen und Immunreaktionen auf virale Vektoren |
| PT2768942T (pt) | 2011-10-17 | 2020-01-21 | Massachusetts Inst Technology | Entrega intracelular |
| CN104684546A (zh) | 2012-06-07 | 2015-06-03 | 哈佛大学校长及研究员协会 | 用于药物靶向的纳米疗法 |
| WO2014165707A2 (en) | 2013-04-03 | 2014-10-09 | Memorial Sloan-Kettering Cancer Center | Effective generation of tumor-targeted t-cells derived from pluripotent stem cells |
| ES2745472T3 (es) | 2013-07-15 | 2020-03-02 | The U S A As Represented By The Secretary Department Of Health And Human Services Office Of Tech Tra | Receptores de células T anti-virus del papiloma humano 16 E6 |
| KR102243597B1 (ko) | 2013-08-16 | 2021-04-26 | 메사추세츠 인스티튜트 오브 테크놀로지 | 세포로의 선택적 물질 전달 |
| KR20170074235A (ko) | 2014-10-31 | 2017-06-29 | 메사추세츠 인스티튜트 오브 테크놀로지 | 면역 세포로의 생체분자의 전달 |
| RS58080B1 (sr) * | 2014-11-04 | 2019-02-28 | Janssen Vaccines & Prevention Bv | Terapeutske vakcine protiv hpv16 |
| CN107002089B (zh) | 2014-11-14 | 2021-09-07 | 麻省理工学院 | 化合物和组合物向细胞中的破坏和场实现的递送 |
| CN107250373A (zh) | 2015-01-12 | 2017-10-13 | 麻省理工学院 | 通过微流体递送实现的基因编辑 |
| AU2016289530B2 (en) | 2015-07-09 | 2021-05-06 | Massachusetts Institute Of Technology | Delivery of materials to anucleate cells |
| PL3344747T3 (pl) | 2015-09-04 | 2023-06-19 | Sqz Biotechnologies Company | Wewnątrzkomórkowe dostarczanie biocząsteczek za pośrednictwem powierzchni z porami |
| EP3344575B1 (en) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| JP7019578B2 (ja) | 2015-12-30 | 2022-02-15 | セルジーン コーポレイション | Ｔリンパ球の産生方法及びそれにより産生されるｔリンパ球 |
| JP7033535B2 (ja) | 2016-01-12 | 2022-03-10 | スクイーズ バイオテクノロジーズ カンパニー | 複合体の細胞内送達 |
| AU2017259988B2 (en) | 2016-05-03 | 2023-04-27 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to induce tolerance |
| CA3023092A1 (en) | 2016-05-03 | 2017-11-09 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to induce tolerance |
| US11422127B2 (en) | 2016-12-07 | 2022-08-23 | Albany Medical College | Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens |
| CN106632694B (zh) * | 2017-01-24 | 2021-02-12 | 南京益康生物医药有限公司 | 一种重组蛋白及药物组合物与应用 |
| EP3720878A1 (en) | 2017-12-05 | 2020-10-14 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to modulate antibody production |
| EP3728559A1 (en) | 2017-12-20 | 2020-10-28 | SQZ Biotechnologies Company | System for delivery of a payload into a cell |
| AU2019234549B2 (en) | 2018-03-12 | 2026-02-12 | Sqz Biotechnologies Company | Methods for treating HPV-associated diseases |
| US20240374654A2 (en) | 2018-03-12 | 2024-11-14 | Stemcell Technologies Canada Inc. | Intracellular delivery of biomolecules to modify immune response |
| US20210388390A1 (en) | 2018-10-04 | 2021-12-16 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to enhance antigen presenting cell function |
| WO2020154696A1 (en) | 2019-01-25 | 2020-07-30 | Sqz Biotechnologies Company | Anucleate cell-derived vaccines |
| CA3131701A1 (en) | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
| KR20210149791A (ko) | 2019-04-08 | 2021-12-09 | 에스큐지 바이오테크놀로지스 컴퍼니 | 페이로드를 세포 내로 전달하기 위한 시스템에서 이용하기 위한 카트리지 |
-
2019
- 2019-03-11 AU AU2019234549A patent/AU2019234549B2/en active Active
- 2019-03-11 TW TW108108097A patent/TW202003025A/zh unknown
- 2019-03-11 JP JP2020548799A patent/JP2021517895A/ja active Pending
- 2019-03-11 SG SG11202008863XA patent/SG11202008863XA/en unknown
- 2019-03-11 WO PCT/US2019/021703 patent/WO2019178005A2/en not_active Ceased
- 2019-03-11 KR KR1020207028582A patent/KR20200130371A/ko active Pending
- 2019-03-11 MA MA052003A patent/MA52003A/fr unknown
- 2019-03-11 MX MX2020009441A patent/MX2020009441A/es unknown
- 2019-03-11 IL IL277190A patent/IL277190B2/en unknown
- 2019-03-11 BR BR112020018609-0A patent/BR112020018609A2/pt unknown
- 2019-03-11 CA CA3093826A patent/CA3093826A1/en active Pending
- 2019-03-11 US US16/980,341 patent/US12599656B2/en active Active
- 2019-03-11 PE PE2020001397A patent/PE20201201A1/es unknown
- 2019-03-11 CN CN201980030616.4A patent/CN112105383A/zh active Pending
- 2019-03-11 CR CR20200461A patent/CR20200461A/es unknown
- 2019-03-11 EP EP19713307.7A patent/EP3765073A2/en active Pending
-
2020
- 2020-09-11 PH PH12020551437A patent/PH12020551437A1/en unknown
- 2020-10-09 CO CONC2020/0012583A patent/CO2020012583A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021517895A5 (enExample) | ||
| JP2021517813A5 (enExample) | ||
| Ramos da Silva et al. | Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice | |
| US12252699B2 (en) | Method for generating t-cells compatible for allogenic transplantation | |
| TWI904084B (zh) | 投遞生物分子至周邊血液單核細胞（ｐｂｍｃ）以調節免疫反應 | |
| Quayle et al. | CUE-101, a novel E7-pHLA-IL2-Fc fusion protein, enhances tumor antigen-specific T-cell activation for the treatment of HPV16-driven malignancies | |
| JP5070045B2 (ja) | 新規人工抗原提示細胞およびそれらの用途 | |
| Xie et al. | The role of CD4+ T cells in tumor and chronic viral immune responses | |
| Rickinson et al. | Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory | |
| IL277188B1 (en) | Intracellular delivery of biomolecules to modify the immune response | |
| BR112021003305A2 (pt) | métodos para produzir células que expressam receptor de antígeno quimérico | |
| JP2022522351A5 (enExample) | ||
| Salerno-Gonçalves et al. | Cell-mediated immunity and the challenges for vaccine development | |
| JP2017533702A (ja) | 生体分子の免疫細胞への送達 | |
| CN105378068A (zh) | 用于免疫治疗的同种异体且高活性的t细胞的工程化方法 | |
| CN104411819A (zh) | 用于过继细胞疗法的改进的细胞培养方法 | |
| Tellam et al. | mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells | |
| CA2831294A1 (en) | Compositions and methods to immunize against hepatitis c virus | |
| O'Sullivan et al. | Generation of natural killer cell memory during viral infection | |
| US20230263879A1 (en) | Methods to stimulate hla-agnostic immune responses to proteins using nucleated cells | |
| JP2022514116A (ja) | 新規な癌抗原及び方法 | |
| JP2023539370A5 (enExample) | ||
| Zanetti et al. | B lymphocytes as antigen‐presenting cell‐based genetic vaccines | |
| Garidou et al. | Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection | |
| Tzannou et al. | Accelerating immune reconstitution after hematopoietic stem cell transplantation |